This course discusses the human herpesviruses (HHVs) and their adverse affects from cold sores to cancer, from trivial to debilitating, from self-limiting to lethal. A review of the research is presented with a focus on a relatively new anti-HHV medication - Viroxyn® and Private Label Store Brand equivalents. This is an exciting, new addition to the anti-HHV armamentarium: the first treatment system to capitalize on the topical, microbicidal approach in a field currently dominated by systemic, anti-DNA nucleosides. Your effective application of these treatments may help improve quality of life for your HSV-1 patients and their families. With this knowledge you may even save lives.
Read more